We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
+42.01%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$171M
AUM Growth
+$19.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$70.1M 40.96%
19,363,975
PLRX icon
2
Pliant Therapeutics
PLRX
$64.4M
$44.6M 26.04%
2,132,867
RVMD icon
3
Revolution Medicines
RVMD
$39.9B
$28M 16.36%
1,419,900
FULC icon
4
Fulcrum Therapeutics
FULC
$273M
$19M 11.08%
2,343,154
DNTH icon
5
Dianthus Therapeutics
DNTH
$5.84B
$9.53M 5.57%
422,388

Similar funds

TRV GP IV's Q3 2022 Portfolio in Review

As of Q3 2022, TRV GP IV held 5 positions worth $171M, up 13% from $152M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's ten largest holdings make up 100% of its $171M portfolio in Q3 2022.
  • TRV GP IV opened 0 new positions and closed 0 in Q3 2022.
  • TRV GP IV's portfolio value rose 13% quarter-over-quarter to $171M.

Based on TRV GP IV's 13F filing for Q3 2022, filed 3 Nov 2022.